None
Quote | Predictive Oncology Inc. (NASDAQ:POAI)
Last: | $1.6898 |
---|---|
Change Percent: | 26.1% |
Open: | $1.48 |
Close: | $1.34 |
High: | $1.85 |
Low: | $1.4 |
Volume: | 222,467 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
News | Predictive Oncology Inc. (NASDAQ:POAI)
2024-04-25 13:06:40 ET Gainers: Loar Holdings ( LOAR ) +63% . Safe & Green Holdings Corp ( SGBX ) +61% . YY Group Holding Limited Class A Ordinary Shares ( YYGH ) +50% . Barfresh Food Group ( BRFH ) +40% . Processa Pharmaceuticals ( ...
2024-04-25 10:00:28 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance BofA watched clients retract $2B last week as the S&P dropped ...
Message Board Posts | Predictive Oncology Inc. (NASDAQ:POAI)
Subject | By | Source | When |
---|---|---|---|
This will be back below a dollar sooner | Distantpulse | investorshub | 04/26/2023 9:51:16 PM |
I blame it on AI. First $POAI did | 77Port | investorshub | 04/24/2023 7:00:51 PM |
There will be a lawsuit and we will | Distantpulse | investorshub | 04/24/2023 3:10:26 PM |
$POAI: new motto. We destroy shareholders to | 77Port | investorshub | 04/24/2023 2:16:09 PM |
$POAI is now VERY thin GREEEN we come | knrorrel | investorshub | 04/18/2023 2:26:35 PM |
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
26.1%Change Percent:
Predictive Oncology Inc. Company Name:
POAI Stock Symbol:
NASDAQ Market:
PITTSBURGH, April 24, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ:POAI), a leader in AI-driven drug discovery and biologics, toda...
PITTSBURGH, April 24, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today announced that an abstract has been accepted for presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, which is be...
PITTSBURGH, March 28, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI) , a science driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, CLIA laboratory and GMP facility, to accelerate onc...